December 17, 2025
Secondary Diagnosis Reporting in Inpatient Coding: Why the Details Matter
Why Accurate Secondary Diagnosis Reporting Is Critical
Understanding when a condition meets coding guidelines for reporting as a secondary diagnosis is critical to ensuring that coded data accurately represents patient care. Precise code assignment influences quality reporting, performance metrics, and reimbursement. When secondary conditions are incorrectly coded—whether through overcoding or underreporting—it can lead to significant consequences such as compliance risks, audit exposure, inaccurate quality scores, and misrepresentation of both patient acuity and organizational performance.
Applying the Official Definition of “Other (Additional) Diagnoses”
A secondary diagnosis is reportable when it affects patient care by requiring one or more of the following:
- Clinical evaluation: The provider assesses or monitors the condition (e.g., monitoring symptoms, evaluating serial lab tests, imaging, or specialist consultation).
- Therapeutic treatment: The condition receives active treatment (e.g., medication management, wound care, transfusion).
- Diagnostic procedures: Testing is performed to evaluate the condition.
- Extended length of stay or Increased nursing care: The condition contributes to increased complexity or length of stay.
Identifying Valid Secondary Diagnoses Through Clinical Indicators
A diagnosis listed in the past medical history or mentioned once in the record should not automatically be reported. Coders must review the chart for evidence that the condition was evaluated, treated, or influenced care.
Examples:
- Reportable: Hypertension requiring daily medication during admission for pneumonia is reportable as a secondary diagnosis.
- Not reportable: Glaucoma noted solely in past medical history, without current treatment or clinical impact during an admission for cholecystitis/cholecystectomy, does not meet criteria for reporting as a secondary diagnosis.
Documentation Requirements for Secondary Diagnosis Assignment & Common Pitfalls
If documentation is unclear, inconsistent, or conflicts with clinical findings, query the provider.
- Documentation of pancytopenia, platelets within normal range.
Pitfalls:
- Coding incidental findings that did not impact care.
- Assigning chronic conditions without evidence of evaluation or management.
- Reporting resolved problems from prior admissions not addressed in current encounter.
Annette Brehl, RHIA, CCS, CCS-P
Senior Consultant, Quality at UASI
Annette Brehl is an Inpatient Coding Auditor and Educator at UASI, known for elevating coding quality through in-depth documentation analysis, a strong command of regulatory and coding guidelines, and targeted education. She shares coding tips informed by audit findings that helpcoders strengthen their accuracy, consistency, and confidence.
Works Cited
Centers for Medicare & Medicaid Services. (2025). ICD-10-CM Official Guidelines for Coding and Reporting, FY 2026.
Available at
https://www.cms.gov/files/document/fy-2026-icd-10-cm-coding-guidelines.pdf
Learn the symptoms of PRES, key treatment considerations, ICD-10-CM code I67.83, and documentation tips for CDI and accurate DRG assignment.
Understand ICANS documentation and ICD-10 coding with guidance on the ICANS grading system, ICE score, clinical indicators, and CAR T-cell neurotoxicity.
Gestational Diabetes
Learn how to identify, document, and code acute kidney injury (AKI), including diagnostic criteria, staging, ICD-10-CM guidance, and CDI query considerations.
Learn how firearm injury intent is documented and reported in ICD-10-CM, including intent categories, external cause codes, and documentation considerations.
Learn how ventricular standstill is documented and coded, including clinical indicators, ICD-10-CM guidance, and common documentation considerations.
Learn how neurostorming, also known as paroxysmal sympathetic hyperactivity (PSH), is documented and coded using ICD-10-CM guidance.
Background: With the 2026 IPPS Proposed Final Rule comes a new diabetes code, E11.A, Type II diabetes mellitus without complications in remission. This is a non-CC/MCC and is assigned to MDC 10. ICD-10-CM Official Guidelines for Coding and Reporting 2026: Section I.C.4.a.1.(b) - “Code E11.A, Type 2 diabetes mellitus without complications in remission, is assigned based on provider documentation that the diabetes mellitus is in remission. If the documentation is unclear as to whether the Type 2 diabetes mellitus has achieved remission, the provider should be queried. For example, the term “resolved” is not synonymous with remission.” Clinical criteria for diabetes in remission: Note* - Remission does not mean cure. Ongoing monitoring is essential as relapse is possible. 1. Prior Diagnosis of Diabetes Mellitus Documented history of type 2 diabetes mellitus, diagnosed using standard criteria: HbA1c ≥ 6.5% Fasting plasma glucose ≥ 126 mg/dL 2-hour plasma glucose ≥ 200 mg/dL during an OGTT Random plasma glucose ≥ 200 mg/dL with classic symptoms 2. Normal or Controlled Glucose Levels Without Medications The patient is not taking any antidiabetic medications (oral agents, insulin, or non-insulin injectables). Glycemic control is sustained through lifestyle modifications, such as diet and exercise. HbA1c < 6.5%, and sometimes < 6.0%, on two occasions at least 6 months apart without pharmacologic therapy. 3. Duration of Remission Partial remission: HbA1c < 6.5% and fasting glucose 100–125 mg/dL for at least 1 year without medications. Complete remission: HbA1c in the normal range (<5.7%) and fasting glucose <100 mg/dL for at least 1 year. Prolonged remission: Complete remission lasting ≥5 years. 4. Documentation Must Include Clear statement that diabetes is in remission or resolution. No current use of diabetes medications. Current HbA1c values. Lifestyle interventions being used. Absence of ongoing diabetic complications (or if present, they are noted as sequelae) 5. What about Type I diabetes? Is remission associated? “Honeymoon Phase” vs. Remission Some individuals newly diagnosed with type 1 diabetes may experience a "honeymoon phase": This is a temporary period (weeks to months) where insulin needs to decrease and blood glucose levels may normalize. However, this is not true remission, as the autoimmune process continues and insulin dependence eventually returns. Clinical Scenario Dr. Doctor, Documentation in your visit note indicates the patient has a documented history of type 2 diabetes mellitus, but current labs show: HbA1c: 5.6% No diabetes medications (e.g., insulin, metformin) currently prescribed Patient reports lifestyle changes (e.g., diet and weight loss) No hyperglycemia documented during this admission or recent visits Query Based on the clinical picture, can you please clarify the patient’s current diabetic status? ☐ Type 2 diabetes mellitus – continue to document and treat as active ☐ History of type 2 diabetes mellitus, currently in remission (no medications, normal glucose values) ☐ Other: ________________
Definition: Neonatal encephalopathy (NE) is a clinically defined syndrome of disturbed neurologic function in the earliest days of life in a term or late preterm infant, manifested by difficulty with initiating and maintaining respiration, depression of tone and reflexes, subnormal level of consciousness, and often seizures. Clinical presentation: Low APGAR scores and/or weak/absent cry in the delivery room. Hyperalert, irritable, lethargic, obtunded. Decreased spontaneous movements, poor tone, blunted or absent primitive reflexes, seizure activity. Breathing and/or feeding difficulties. Documentation Tips: The CDS should review to identify the underlying etiology . (e.g., hypoxic-ischemic event, infection, metabolic disorder). Review clinical indicators that may indicate associated conditions , such as seizures, abnormal imaging, acidosis, or multi-organ dysfunction. Review the documentation for the timing of onset (e.g., at birth, delayed). Common clinical indicators include low APGAR scores, need for resuscitation, abnormal tone, or altered level of consciousness. ICD-10-CM Coding: P91.811, Neonatal encephalopathy in diseases classified elsewhere P91.819, Neonatal encephalopathy, unspecified Use when the type or etiology of NE is not documented Query Example: To the Attending Neonatologist: Documentation in the medical record indicates the newborn infant delivered from mother with placental abruption demonstrates seizures, abnormal muscle tone, low APGAR scores, and required resuscitation at birth. Imaging showed evidence of cerebral edema. The diagnosis of “neonatal encephalopathy” was documented in the assessment. Query: Based on the clinical indicators, can you clarify the type and cause of the encephalopathy in this newborn? Please select the most appropriate option below or specify another diagnosis: Neonatal encephalopathy due to Hypoxic-ischemic encephalopathy (HIE) Neonatal encephalopathy due to other etiology (please specify) Other (please specify): __________
Definition: Tumor lysis syndrome (TLS) is an oncologic emergency caused by massive tumor cell lysis and the release of large amounts of potassium, phosphate, and uric acid into the systemic circulation. Deposition of uric acid and/or calcium phosphate crystals in the renal tubules can result in acute kidney injury.
